Sarepta Therapeutics
Develops Duchenne muscular dystrophy medicines and genetic therapies for rare diseases.
$21.05
After-hours close+0.21 (+0.98%)
At close$20.85(−3.45%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.39 | — | — |
| Aug 2026 | $0.22 | −$0.05 | −123.0% |
| May 2026 | $0.98 | $3.16 | +223.8% |
| Feb 2026 | −$1.03 | −$3.58 | −247.6% |
| Nov 2025 | $0.01 | −$0.13 | −1,400.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | $0.39 | — | — | $354.4M | — | — |
| Aug 5, 2026 | $0.22 | −$0.05 | −123.0% | $366.4M | $401.3M | +9.5% |
| May 6, 2026 | $0.98 | $3.16 | +223.8% | $474.2M | $730.8M | +54.1% |
| Feb 25, 2026 | −$1.03 | −$3.58 | −247.6% | $369.6M | $442.9M | +19.8% |
| Nov 3, 2025 | $0.01 | −$0.13 | −1,400.0% | $391.4M | $399.4M | +2.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 1, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 2, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 2, 2022 | ||||||
| May 4, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Mar 1, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 6, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 8, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Oct 24, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 3, 2018 | ||||||
| Mar 1, 2018 | ||||||
| Oct 25, 2017 | ||||||
| Jul 19, 2017 | ||||||
| Apr 27, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Oct 27, 2016 | ||||||
| Jul 19, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 6, 2015 | ||||||